These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 337417)

  • 1. [Streptococcus agalactiae (Streptococcus group B): clinical and bacteriological aspects].
    Soriano García F; Elola-Olaso A; Gómez Garcés JL; Ponte Miramontes MC; Ales Reinlein JM
    Rev Clin Esp; 1977 Sep; 146(5):217-20. PubMed ID: 337417
    [No Abstract]   [Full Text] [Related]  

  • 2. Invasive group B Streptococcus isolates showing reduced susceptibility to penicillin in Hong Kong.
    Chu YW; Tse C; Tsang GK; So DK; Fung JT; Lo JY
    J Antimicrob Chemother; 2007 Dec; 60(6):1407-9. PubMed ID: 17959733
    [No Abstract]   [Full Text] [Related]  

  • 3. Ability of the VITEK(R) 2 system to detect group B streptococci with reduced penicillin susceptibility (PRGBS).
    Kimura K; Nagano N; Nagano Y; Wachino J; Shibayama K; Arakawa Y
    J Antimicrob Chemother; 2013 Jun; 68(6):1442-4. PubMed ID: 23378415
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antimicrobial susceptibility of Streptococcus agalactiae strains in Monastir].
    Sahnoun O; Ben Abdallah H; Noomen S; Ben Elhadj Khélifa A; Mastouri M
    Med Mal Infect; 2007 Nov; 37(11):734-7. PubMed ID: 17459635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sensitivity of Streptococcus A and B towards penicillin G, penicillin V, ampicillin and amoxicillin].
    Chabbert YA; Horodniceanu T
    Nouv Presse Med; 1975 Oct; 4(34):2437-40. PubMed ID: 812058
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998.
    Lin FY; Azimi PH; Weisman LE; Philips JB; Regan J; Clark P; Rhoads GG; Clemens J; Troendle J; Pratt E; Brenner RA; Gill V
    Clin Infect Dis; 2000 Jul; 31(1):76-9. PubMed ID: 10913400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of plasmid-mediated resistance after conversion of a group B streptococcus strain to a stable cell wall deficient variant.
    Schmitt-Slomska J; Caravano R; El-Solh N
    Ann Microbiol (Paris); 1979 Jan; 130 A(1):23-7. PubMed ID: 382949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of chemotherapeutics on the species streptococcus in vitro.
    Výmola F; Jedlicková Z
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(3):383-8. PubMed ID: 1102599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent infection associated with penicillin-tolerant group B streptococci: a report of two cases.
    Siegel JD; Shannon KM; DePasse BM
    J Pediatr; 1981 Dec; 99(6):920-4. PubMed ID: 7031213
    [No Abstract]   [Full Text] [Related]  

  • 10. [Efficacy of gentamycin combined with beta-lactam antibiotics against penicillin-resistant and non-resistant Streptococcus agalactiae].
    Villar H; Jugo M; Farinati A
    Enferm Infecc Microbiol Clin; 1994 Oct; 12(8):385-9. PubMed ID: 7981289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic resistance patterns of group B streptococcal clinical isolates.
    Simoes JA; Aroutcheva AA; Heimler I; Faro S
    Infect Dis Obstet Gynecol; 2004; 12(1):1-8. PubMed ID: 15460188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimicrobial susceptibilities and serotype distribution of Streptococcus agalactiae strains isolated from pregnant women].
    Yenişehirli G; Bulut Y; Demirtürk F; Calişkan AC
    Mikrobiyol Bul; 2006 Jul; 40(3):155-60. PubMed ID: 17001843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapy.
    Longtin J; Vermeiren C; Shahinas D; Tamber GS; McGeer A; Low DE; Katz K; Pillai DR
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2983-5. PubMed ID: 21383092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penicillin tolerance in group B streptococci.
    Broadbent A
    J Antimicrob Chemother; 1984 Apr; 13(4):396-7. PubMed ID: 6373718
    [No Abstract]   [Full Text] [Related]  

  • 15. [Occurrence and drug-resistance of beta-hemolytic streptococci].
    Mikołajczyk D; Budzyńska A; Kaczmarek A; Gospodarek E
    Med Dosw Mikrobiol; 2007; 59(4):301-7. PubMed ID: 18416122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The sensitivity of group B streptococci (Streptococcus agalactiae) to antibacterial substances].
    Jedlicková Z; Výmola F
    Cesk Pediatr; 1984 May; 39(5):297-9. PubMed ID: 6380774
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of the activity of tigecycline against multiresistant clinical isolates of Staphylococcus aureus and Streptococcus agalactiae.
    Sorlozano A; Gutierrez J; Roman E; de Dios Luna J; Roman J; Liebana J; Piedrola G
    Diagn Microbiol Infect Dis; 2007 Aug; 58(4):487-9. PubMed ID: 17509803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The penicillin resistance of Streptococcus agalactiae isolated before and after penicillin therapy.
    FORD CM; WILSON JB
    Cornell Vet; 1952 Jul; 42(3):291-5. PubMed ID: 14936425
    [No Abstract]   [Full Text] [Related]  

  • 19. Group B streptococcal antibiotic resistance patterns in pregnant women.
    Stiller RJ; Padilla L; Choudhary R; Tinghitella T; Laifer S
    Conn Med; 2003; 67(6):323-6. PubMed ID: 12956041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand.
    Malbruny B; Werno AM; Anderson TP; Murdoch DR; Leclercq R
    J Antimicrob Chemother; 2004 Dec; 54(6):1040-4. PubMed ID: 15537693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.